Stocks · Health care · Pharmaceutical Preparations

Amylyx Pharmaceuticals, Inc.

AMLX Clue Score40
United States Fiscal year ends December CIK 0001658551 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
George M Milne Jr
5 Oct 2026
Director
Sold on a plan
30,000
$27.70
$830.90K
Gina Mazzariello
10 Jul 2026
Chief Legal Officer
Sold on a plan
15,000
$17.61
$264.12K
Gina Mazzariello
9 Jul 2026
Chief Legal Officer
Sold on a plan
15,000
$18.32
$274.75K
Gina Mazzariello
13 Aug 2025
Chief Legal Officer
Sold on a plan
15,000
$8.34
$125.05K
Gina Mazzariello
12 Aug 2025
Chief Legal Officer
Sold on a plan
15,000
$8.07
$121.10K
Gina Mazzariello
15 May 2024
Chief Legal Officer
Sold on a plan
10,455
$1.88
$19.65K
Gina Mazzariello
15 Aug 2023
Chief Legal Officer
Sold on a plan
6,164
$20.88
$128.69K

What was left out

Form 4 filings counted 178
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 9
Sales at will 117
Transactions with no price 0
Shares from compensation/vesting 38,287,796
Sales filed before the plan box existed 42
History held since 10 Jan 2022